HC Wainwright reiterated their buy rating on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) in a research report released on Wednesday, MarketBeat reports. HC Wainwright currently has a $20.00 target price on the biotechnology company’s stock. A number of other equities research analysts have also recently commented on ENTA. Wall Street Zen cut shares […]

Ligand Pharmaceuticals (NASDAQ:LGND – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued to investors on Thursday, Benzinga reports. They currently have a $358.00 price objective on the biotechnology company’s stock. HC Wainwright’s target price would indicate a potential upside of 19.40% from the […]

HC Wainwright reaffirmed their buy rating on shares of Corcept Therapeutics (NASDAQ:CORT – Free Report) in a report issued on Friday morning,Benzinga reports. HC Wainwright currently has a $165.00 target price on the biotechnology company’s stock. Other equities analysts have also issued reports about the company. Wolfe Research lowered Corcept Therapeutics from a “peer perform” […]

Cogent Biosciences (NASDAQ:COGT – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $55.00 price objective on the technology company’s stock. HC Wainwright’s price target suggests a potential upside of 65.79% from the stock’s […]

Solid Biosciences (NASDAQ:SLDB – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a note issued to investors on Monday, Benzinga reports. They presently have a $25.00 price target on the stock. HC Wainwright’s price target suggests a potential upside of 187.36% from the company’s previous close. […]

HC Wainwright reaffirmed their buy rating on shares of Rockwell Medical (NASDAQ:RMTI – Free Report) in a research note issued to investors on Friday,Benzinga reports. They currently have a $20.00 price objective on the stock. HC Wainwright also issued estimates for Rockwell Medical’s Q1 2027 earnings at $0.02 EPS, Q4 2027 earnings at $0.14 EPS […]

HC Wainwright restated their buy rating on shares of GRI Bio (NASDAQ:GRI – Free Report) in a research report sent to investors on Thursday morning,Benzinga reports. The firm currently has a $10.00 target price on the stock. Several other equities research analysts have also recently commented on the stock. Weiss Ratings reaffirmed a “sell (e+)” […]

HC Wainwright reissued their buy rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a report issued on Thursday morning, Marketbeat Ratings reports. They currently have a $22.00 price objective on the stock. A number of other research analysts also recently issued reports on the stock. Wedbush started coverage on shares of Immunic in […]

HC Wainwright reissued their buy rating on shares of BridgeBio Pharma (NASDAQ:BBIO – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $120.00 price objective on the stock. A number of other equities research analysts also recently issued reports on BBIO. Bank of America increased their price objective on […]